CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
In a small group of patients with hereditary ATTR amyloidosis with polyneuropathy, administration of NTLA-2001 was associated with only mild adverse events and led to decreases ...
Publications
View AllAffiliated Researchers
Institution Info
- Type
- facility
- Country
- NZ
- Publications
- 1
- Citations
- 1,432
External Links
Identifiers
- ROR
- https://ror.org/0312ka630